Search Result "SU6656"
The Src Family Kinase Inhibitors PP2 and PP1 Block TGF-Beta1-Mediated Cellular Responses by Direct and Differential Inhibition of Type I and Type II TGF-Beta Receptors
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 4 Year: 2011 Page: 524-535
Author(s): H. Ungefroren, S. Sebens, S. Groth, F. Gieseler, F. Fandrich
TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 7 Year: 2017 Page: 966-972
Author(s): Tobias Bartscht,Benjamin Rosien,Dirk Rades,Roland Kaufmann,Harald Biersack,Hendrik Lehnert,Hendrik Ungefroren
Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1727-1737
Author(s): Petra Luskova, Petr Draber
Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Journal: Current Molecular Medicine
Volume: 14 Issue: 5 Year: 2014 Page: 663-672
Author(s): W. Wang,Y. Ye,J. Li,X. Li,X. Zhou,D. Tan,Y. Jin,E. Wu,Q. Cui,M. Wu
A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2012 Page: 5294-5318
Author(s): P. Robak, T. Robak
Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5865-5872
Author(s): Howar S. Kruth
The Role of Shcbp1 in Signaling and Disease
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 854-862
Author(s): Geng-Yuan Zhang,Zhi-Jian Ma,Long Wang,Ruo-Fei Sun,Xiang-Yan Jiang,Xu-Juan Yang,Bo Long,Hui-Li Ye,Shu-Ze Zhang,Ze-Yuan Yu,Wen-Gui Shi,Zuo-Yi Jiao
Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 10 Year: 2017 Page: 1351-1356
Author(s): Tobias Bartscht,Benjamin Rosien,Dirk Rades,Roland Kaufmann,Harald Biersack,Hendrik Lehnerta,Hendrik Ungefroren
The Development of 3-substituted Indolin-2-one Derivatives as KinaseInhibitors for Cancer Therapy
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 11 Year: 2022 Page: 1891-1919
Author(s): Changqing Xu,Yang Liu,Guisen Zhao
Transactivation of EGFR by G Protein-Coupled Receptor in the Pathophysiology of Intimal Hyperplasia
Journal: Current Vascular Pharmacology
Volume: 12 Issue: 2 Year: 2014 Page: 190-201
Author(s): Swastika Sur,Devendra K. Agrawal